FdaApplication
ANDA 214688
Identifiers
- fda_app_no: ANDA214688
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2023-03-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE | 0.064%;0.005% | AEROSOL, FOAM;TOPICAL |
1 product